Zum Inhalt springen

Francesco Bertoni

@frbertoni.bsky.social did:plc:am3g2x2ua4npyujnygdinh32

Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma

Bei Bluesky seit

Follower
130
Folgt
190
Posts
65
Tage in Ranglisten
0

Zusammenfassung

Francesco Bertoni (@frbertoni.bsky.social) ist seit 15 April 2025 auf Bluesky. Das Konto hat 130 Follower, folgt 190 Konten und hat 65 Posts veröffentlicht.

Ranglisten-Platzierungen

Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.

Dieses Konto war noch in keiner Tagesrangliste.

Zuletzt gelikte Posts

Öffentliche Likes aus dem Bluesky-Netzwerk.

  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Shannon Buckley, Francesco Bertoni, and Justin Taylor discussed "Degraders in Lymphoma" during a plenary session at the AACR Conference on Advances in Malignant Lymphoma. #AACRlymphoma26 @frbertoni.bsky.social

    Post anzeigen
  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Degraders in Lymphoma: Shannon Buckley, Francesco Bertoni, and Justin Taylor will address this topic in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/XH3lbfr #AACRlymphoma26 @frbertoni.bsky.social

    Post anzeigen
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

    Post anzeigen
  • International Conference on Malignant Lymphoma@icmlugano.bsky.social

    Yesterday we had our first 19-ICML Local Organising Committee meeting — the behind-the-scenes work for the next edition has officially begun! 💥 @frbertoni.bsky.social #19ICML #ICML #lymphoma #CLL #myeloma #lymssm

    Post anzeigen
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

    Post anzeigen

Melde dich an, um mehr zu sehen

Blockierte Konten

Blockierungen sind auf Bluesky öffentlich.